Running title: miR-155/Pdcd4/AP-1 feedback loop in tongue cancer.
mainly controlled via Activation protein-1 (AP-1), (-36bp upstream of start site) and NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), (-1150 upstream from start site) transcription factors present upstream of core promoter region (29) . AP-1, formed by the heterodimerization between members of JUN and FOS protein families, is a critical regulator of cell proliferation, apoptosis, tumor invasiveness, angiogenesis and other multiple hallmarks of cancer (30) (31) (32) .
In this study, we demonstrate that miR-155 is overexpressed in tongue cancer cells (SAS and AWL) and tongue tumor tissues when compared to normal FBM cells and normal tongue tissues, respectively. We All these result clearly indicates that SAS and AWL cells shows inverse relationship for the expression levels of miR155 and Pdcd4 ( Figure. 1B and 1C) as often seen in miRNA-target pairs in cancer cells (33) .
Since miR-155 and Pdcd4 expression levels in SAS and AWL cells show inverse relation, it was relevant
to check if there is an inverse relationship in their expression in tongue cancer tissues and to this end, we analyzed miR-155 and Pdcd4 levels in 18-pairs of tongue cancer patient samples (adjacent normal and tumor). miR-155 expression was found to be higher in most of the tumor tissues (except patient 6) compared to their adjacent normal tissue sections when analyzed by qPCR ( Figure. 1D ). As expected, Pdcd4 mRNA levels were lower in tongue cancer tissues in comparison to their adjacent normal tissues ( Figure. 1E ). The protein levels of Pdcd4 were detected by western blot for 8 patients and immunohistochemistry for rest for other 18 patients and the results show that Pdcd4 was barely detected in tumor samples compared to normal tissue ( Figure. 1Fand 1G) . These data indicate the existence of inverse correlation in the expression levels of miR-155 and its target, Pdcd4 and prompted us to experimentally validate for the first time if Pdcd4 is a target of miR-155 in tongue cancer cells.
miR-155 negatively regulates Pdcd4 expression
First, we have cloned the wild-type 3'UTR of Pdcd4 (nucleotides 1170-1913) and miR-155 binding site mutant 3'UTR of Pdcd4 into psiCheck-2 (Supplementary Figure. As SAS and AWL cells express high levels of miR-155 ( Figure. 1A and 1B), they were transfected with psiCheck-2, psiCheck-3'UTR of Pdcd4 WT or MUT, and as expected, the renilla luciferase activity showed a significant decrease with psiCheck-Pdcd4 WT but not the other two constructs ( Figure. Taken together, these results show that miR-155 regulates Pdcd4 expression by binding to its 3'UTR in FBM, SCC745, SAS and AWL cell lines. 
miR-155 sponge depletes miR-155 and halts tumorigenic properties of SAS cells
For gaining more mechanistic insights, we generated stable clones of SAS cells that express miR-155 sponge using lentiviruses. The virus titer was optimized for efficient transduction and positively transduced cells were enriched by cell sorting in FACS-ARIA III using GFP as a marker ( Supplementary Figure. 4A ). 
Real

miR-155 sponge inhibits cell viability, arrests cell cycle and induces apoptosis in SAS cells
Since Pdcd4 is known to be upregulated upon induction of apoptosis (36) , it was of interest to check the Tumor weights were also measured at the end of the study, the weight for the xenografts generated by SAS pLCE-miR-155 sponge cells was significantly lower compared to xenografts generated by SAS-pLCEcells ( Figure. 6B ). The expression of miR-155 is elucidated by qPCR from the RNA collected from tumor xenografts generated by SAS pLCE-miR-155 sponge and SAS pLCE cells. We have also performed western blot for Pdcd4 for the same set of tumors and it was found that SAS-miR-155 sponge cells show higher expression of Pdcd4 protein compared to SAS-pLCE cells (Figure. 6C ). We have also performed western blots for GFP from lysates of SAS-pLCE and SAS-pLCE-miR-155 sponge xenografts to clarify that tumors generated in mice are generated by injected cells (Figure. 6D) . The in-vivo study clearly demonstrated that miR-155 knockdown suppressed tumor formation of SAS cells in nude mice.
3 Materials and methods
Cell lines, reagents and plasmids
The cell lines, Hep3B, SiHa, MCF7, MDA-MB231 and H1299, were obtained from NCCS, Pune, India. Addgene, USA. All the pGL-3 BIC promoter plasmids with their respective AP-1 and NF-κB mutant plasmids was a kind gift from Erik K. Flemington, Tulane University, USA.
Construction of 3'UTR reporter for Pdcd4
The 688bp of 3'UTR of PDCD4 was amplified using gene-specific primers (Forward Primer - 
BIC and AP-1 Promoter luciferase assay
The regulation of BIC and 4X-AP-1 promoter by Pdcd4 or miR-155 was performed using different combination of plasmid constructs in HEK293T and SAS cells Table S1, Table S2 , Table S3 and Table S4 .
Further downstream process was performed after 48 h post transfections, by lysing the cells in Passive Lysis
Buffer, and firefly luciferase activity was measured using the Dual Luciferase Assay Kit (no. A2492, Promega) in a luminescence plate reader (Molecular Devices Inc., Sunnyvale, CA, USA), wherein renilla firefly luciferase activity acted as the internal control.
Western blot and immunohistochemistry
All the cell lysates were prepared with RIPA cell lysis buffer and 30μg of protein lysates were loaded per well of 12% SAS-PAGE gel and later transferred to PVDF membrane at a constant current of 220mA for 1-1/2 hours. The membrane was probed by the primary antibody, washed thrice with TBS-T and TBS separately and again probed with secondary antibody conjugated with HRP. All western blots were developed in ChemiDoc western blot apparatus from BioRad. For IHC, the tissue slide was incubated with 1:500 dilution of primary antibody. The slides were scored by the pathologist as the percentage positivity of nuclear or cytoplasmic staining and were graded as a) negative<=5%; b) weak, 5-19%; c) moderate, 20-49%; and d) strong, 50-100%) [26] .
Transfection, RNA extraction, cDNA synthesis and Real-time PCR
We used linear chain PEI for plasmid DNA transfections unless mentioned otherwise [27] . We have optimized transfection efficiency at 2:1 PEI: DNA for FBM, HEK293T, SAS, AWL and SCC745 cells.
The tissue samples were stored in RNase later and stored at -80°C until further use. Total RNA from cells was collected by a TriZol reagent (Invitrogen) as per the manufacturer's protocol. For miRNA cDNA synthesis, stem-loop primer-based PCR protocol was used [28] . For cDNA synthesis, oligodT based conversion of mRNA to cDNA is performed by MMLV reverse transcriptase from life technologies.
miRNA-155 expression was quantified by performing stem-loop reverse transcription followed by quantitative PCR; reverse transcription by MMLV reverse transcriptase (Life Technologies) was performed using miR-155 -specific and U6-specific stem-loop primers. qRT-PCR analysis of miR-155 and Pdcd4 is performed by using sybr green chemistry and quantified by 2-ΔCt and 2-ΔΔCt [29] . The expression of miR-155 is normalized to U6 snRNA and Pdcd4 to β-actin. All qRT-PCR reactions were performed in triplicate.
Production of lentiviruses for stable expression of miR-155 sponge
Lentiviruses were produced by co-transfecting HEK293T cells with pPax2, pMDL-2 and pLCE-miR-155 sponge/pLCE. SAS cells were transduced with the optimized virus titer and incubated in presence of 8 μg/ml polybrene. The positively transduced cells were enriched by cell sorting in FACS-ARIA III by using eGFP to sort the positive clones.
cells were enriched by cell sorting in FACS-ARIA III by using eGFP to sort the positive clones.
Soft agar assay
The cancerous cells have the tendency to grow in an anchorage-independent manner and hence have a tendency to form colonies in a semi-solid medium such as soft agar. The anchorage-independent growth of the SAS-pLCE and SAS-miR-155 sponge cells was analyzed by the soft agar assay in 6 well tissue culture plates. DMEM 10% FBS with 0.7% soft agar is poured first in each well of 6 well plate with utmost precision not to include air bubbles, later 3000 cells were mixed with 1 ml of DMEM 10% FBS with 0.35% soft agar and poured over base agar. The cells were allowed to grow in 5% C02 incubator at 37°C for 25
days with the addition of 500μl for liquid DMEM containing 10% FBS after every three days.
Clonogenic assay
For the clonogenic assay, 300 SAS-pLCE and SAS-miR-155 sponge cells were plated per well in 6 well plates. Cells were allowed to form colonies for 25 days and later fixed in methanol and stained with crystal violet. A colony of cells was considered as prominent if it contained 50 cells or more.
Cell cycle analysis
The cell cycle analysis of SAS-pLCE and SAS-miR-155 sponge cells was performed by the FACS-Calibur flow cytometer after staining the cells with propidium iodide. We have followed the end to end protocol as Tumor growth was monitored, and its volume was measured every 5 days till 35th day. Tumor volume (V) was calculated as L*W2/2, where L and W represent large and small diameters of tumor formed, respectively. Tumor weight was measured at the end of the study. All nude mice experiments were approved by the institutional animal ethics committee.
Statistical analysis
Experiments were carried out in triplicate. Data are presented in means plus or minus the standard deviation of the mean. The differences between test and control groups were analyzed using the Graph Prism
Program. The statistical analysis is performed by column comparing between samples of different nature.
Unpaired t-test is performed when comparing two samples involved in experiment. One way ANOVA with multiple comparison is performed when comparing the three or more samples involved in a single experiment. After performing statistical analysis, P-values were calculated and represented as *P< 0.05, **P< 0.01, ***P< 0.001 or ****P<0.0001.
DISCUSSION
The deregulation of gene expression is often associated with various cancerous phenotypes like proliferation, invasion, metastasis and migration. The identification of molecular players that play key roles in gene expression such as miRNAs are relevant for effective therapeutic strategies. Various experimental evidences indicate that some miRNAs like miR-21 (37) and miR-139 (38) and miR-139 [35] form feedback regulatory loops with their targets for their continuous expression to down-regulation their target tumor suppressor mRNA. In this study we have investigated that miR-155 is upregulated in tongue cancer and verified Pdcd4 as its potential target that generates an positive feedback loop with AP-1 to maintain the tumorigenic growth in tongue cancer cells. Even though Pdcd4 is recently shown to be a direct target of miR-155 in non-small cell lung cancer (16) but the data represented in the study is not convincingly shows that 3'UTR of Pdcd4 is a direct of miR-155, as miR-155 binding site mutant seems to be responding to presence of miR-155 and study title seems quite opposite to the study conducted and data represented.
While as our data provide strong evidence that overexpression of miR-155 in tongue cancer cells is due to the positive feedback loop between miR-155/Pdcd4/AP-1. This is the first study to show that miR-155 modulates its own expression by down-regulation of Pdcd4 and activation of AP-1 dependent transcription of BIC promoter in the context of tongue cancer cells ( Figure. 3) . Through a series of in silico, in vitro, and in vivo approaches, we found that miR-155 plays a key role in regulating Pdcd4 by directly targeting its 3'UTR in tongue cancer cells and down-regulating its expression. miR-155 expression is upregulated in solid tumors of diverse origin (23, 39) and consistent with this, we demonstrated that miR-155 expression is significantly higher in tongue cancer tissues and SAS and AWL cells than in adjacent normal tissues and normal FBM cells, respectively, ( Figure. 1 ), suggesting that high miR-155 expression is tightly associated with tongue cancer development. A significant negative correlation between miR-155 expression and that of Pdcd4 protein in maximum number of tongue tumor tissues and SAS and AWL cells observed by us supports the notion that miR-155-mediated control of Pdcd4 is operational in tongue cancer. We have provided several lines of evidence to show that Pdcd4 is directly targeted by miR-155 in FBM, SCC745, SAS and AWL cells for the first time and effect of miR-155 down-regulation on cancerous properties of tongue cancer cells was reflected in-vitro with a decrease in clonogenic capability and anchorageindependent growth on soft agar ( Figure. 4D and 4E ). Furthermore, restoration of Pdcd4 by knockdown of miR-155 was accompanied by decreased cell viability, enhanced apoptosis, and reduction of tumor growth in nude mice. miRNAs usually regulate a large set of targets and our data do not rule out the idea that there may be more targets for miR-155 in addition to Pdcd4. Indeed Pdcd4 has been shown to be targeted by miR-21 in various cancer like hepatocellular carcinoma (40) , oral cancer(4), breast cancer (41), colon carcinoma (42)), miR-96 and miR-183 in glioma (43, 44) , and miR-499 in oropharyngeal cancer (45) .
With respect to the mechanism, our data show that miR-155 acts as a transcriptional regulator of the AP-1 complex by directly targeting Pdcd4, an inhibitor of AP-1 transcription. We found that AP-1 is critical for BIC promoter activity in tongue cancer cells whereas the contribution of NF-κB, was relatively minor. AP-1 activation is often paradoxical as it promotes or inhibits apoptosis in different cellular systems, but our data suggest its role in ensuring tongue cancer cell proliferation emphasizing the need to understand the cellular and extracellular context within which it functions (46) . The inhibition of Pdcd4 by miR-155, in turn, contributes to the increase in AP-1 activity of BIC promoter that explains the enhanced expression of miR-155 in tongue cancer cells, thus revealing a novel miR-155/Pdcd4/AP-1 feedback regulatory mechanism. Inhibition of AP-1 transcription factor by pdcd4 involves Jun-Jun homodimers or Jun-Fos heterodimers (32) . Taken together, our study validates tumour suppressor Pdcd4 as a target of oncogenic miR-155 and the positive feedback loop of miR-155-Pdcd4-AP-1 maintains the miR-155 mediated biological effects of the tongue cancer phenotypic effects ( Figure. 7) . Our data suggest that molecular strategies manipulate miR-155 expression and/or miR-155-Pdcd4-AP-1 feedback loop provide novel avenues to explore in tongue cancer therapeutic.
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